VIGL Archived Articles
Vigil Neuroscience: Pioneering Microglia-Targeted Therapies for Neurodegenerative Diseases
Published on March 17, 2025
Vigil Neuroscience (NASDAQ:VIGL): A Precision Approach to Neurodegenerative Disease
Published on November 30, 2024
Vigil Neuroscience, Inc. (VIGL): A Promising Biotech Poised to Revolutionize Neurodegenerative Disease Treatment
Published on September 24, 2024